News
It starts a project to create a collaborative network for the generation of stem cells compatible with a high percentage of the population
The project aims to create a collaborative network for induced pluripotency stem cells (iPS) homozygous for the most frequent HLA haplotypes generation.
Great success at the Sinergia 2022 Open Day
This Saturday, the Bellvitge Campus opened its doors to bring the research of one of the most important biomedical centers in the country closer to the public. With activities such as guided tours, talks, escape rooms, and gymkhanas the event had a great attendance success.
A new study confirms that deep brain stimulation halves symptoms in severe OCD
This is the second largest sample of patients in the world, treated and followed up by a multidisciplinary team at Bellvitge since 2007. The results suggest that, in addition to reducing obsessive symptoms, the treatment reduces anxiety and depression in these patients.
Researchers validate a microRNA as a biomarker for the diagnosis of azoospermia
A new study confirms the clinical utility of a test based on the quantification of miR-31-5p microRNA levels in semen as a non-invasive biomarker to distinguish the origin of azoospermia
IDIBELL organized a meeting of breast cancer solidarity donors and associations
Yesterday, the breast cancer research team received associations and individuals who, thanks to their donations, have promoted research.
The fourth edition of Sinergia arrives, the festival of health research and innovation of L’Hospitalet
Throughout the week of October 3rd to 8th, gymkhanas, talks, visits, and many other activities will bring science from the Bellvitge Campus closer to the public.
Success of the second symposium of the Oncobell research program
This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals
IDIBELL researchers analyze the evidence of iron supplementation in chronic heart failure
They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.
The IDIBELL-Ins Bellvitge Tandem opens the academic year with the inauguration of new scientific instruments for the secondary school laboratory
During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB